Inactivation of human hepatitis B virus DNA polymerase by pyridoxal 5'-phosphateSANG-HWAN OH; YEON-HEE PARK; KOO WOO et al.Journal of medical virology. 1989, Vol 28, Num 1, pp 42-46, issn 0146-6615Article

Colorimetric assay of matrix metalloproteinase activity based on metal-induced self-assembly of carboxy gold nanoparticlesGAE BAIK KIM; KUN HEE KIM; YEON HEE PARK et al.Biosensors & bioelectronics. 2013, Vol 41, pp 833-839, issn 0956-5663, 7 p.Article

Prognostic Model to Predict Outcomes in Non-Small Cell Lung Cancer Patients with Erlotinib as Salvage TreatmentSEUNG TAE KIM; LEE, Jeeyun; SUN, Jong-Mu et al.Oncology. 2010, Vol 79, Num 1-2, pp 78-84, issn 0030-2414, 7 p.Article

Intensified induction followed by high-dose therapy with autologous peripheral blood stem cell support in poor-prognosis aggressive non-Hodgkin's lymphoma: results of a pilot studyCHOI, Seong-Jun; RYOO, Baek-Yeol; LEE, Seung-Sook et al.Haematologica (Roma). 2002, Vol 87, Num 5, pp 555-557, issn 0390-6078Article

Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOPHYE JIN KANG; WON SEOG KIM; SUH, Cheolwon et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 2, pp 299-304, issn 0344-5704, 6 p.Article

Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancerMYUNG HEE CHANG; JEEYUN LEE; JOUNGHO HAN et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2009, Vol 117, Num 12, pp 861-869, issn 0903-4641, 9 p.Article

Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancerSU JIN LEE; YOON LA CHOI; YEON HEE PARK et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 3, pp 743-751, issn 0344-5704, 9 p.Article

Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapyJONG GWANG KIM; RYOO, Baek-Yeol; YEON HEE PARK et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 2, pp 301-307, issn 0344-5704, 7 p.Article

Clinicopathological features of early failure of neoadjuvant chemotherapy in locally advanced breast cancerMOON KI CHOI; YEON HEE PARK; WON HO KIL et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 3, pp 521-529, issn 0344-5704, 9 p.Article

Accuracy of RECIST 1.1 for non-small cell lung cancer treated with EGFR tyrosine kinase inhibitorsSUN, Jong-Mu; AHN, Myung-Ju; MIN JAE PARK et al.Lung cancer. 2010, Vol 69, Num 1, pp 105-109, issn 0169-5002, 5 p.Article

Genetic polymorphisms of SLC28A3, SLC29A1 and RRM1 predict clinical outcome in patients with metastatic breast cancer receiving gemcitabine plus paclitaxel chemotherapyLEE, Soo-Youn; IM, Seock-Ah; YEON HEE PARK et al.European journal of cancer (1990). 2014, Vol 50, Num 4, pp 698-705, issn 0959-8049, 8 p.Article

Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapySEUNG TAE KIM; JI EUN UHM; AHN, Myung-Ju et al.Lung cancer. 2012, Vol 75, Num 1, pp 82-88, issn 0169-5002, 7 p.Article

Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)EUN YOON CHO; MYUNG HEE CHANG; YOON LA CHOI et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 3, pp 753-761, issn 0344-5704, 9 p.Article

Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancerHYO SONG KIM; YEON HEE PARK; MIN JAE PARK et al.Breast cancer research and treatment. 2009, Vol 118, Num 1, pp 89-97, issn 0167-6806, 9 p.Article

Effect of positive bone marrow EBV in situ hybridization in staging and survival of localized extranodal natural killer/T-cell lymphoma, nasal-typeLEE, Jeeyun; SUH, Cheolwon; HUH, Jooryung et al.Clinical cancer research. 2007, Vol 13, Num 11, pp 3250-3254, issn 1078-0432, 5 p.Article

Clinical Impact of Amphiregulin Expression in Patients With Epidermal Growth Factor Receptor (EGFR) Wild-Type Nonsmall Cell Lung Cancer Treated With EGFR-Tyrosine Kinase InhibitorsMYUNG HEE CHANG; HEE KYUNG AHN; LEE, Jeeyun et al.Cancer. 2011, Vol 117, Num 1, pp 143-151, issn 0008-543X, 9 p.Article

Clinical Impact of Phosphorylated Signal Transducer and Activator of Transcription 3, Epidermal Growth Factor Receptor, p53, and Vascular Endothelial Growth Factor Receptor 1 Expression in Resected Adenocarcinoma of Lung by Using Tissue MicroarrayHYEONG SU KIM; YEON HEE PARK; LEE, Jeeyun et al.Cancer. 2010, Vol 116, Num 3, pp 676-685, issn 0008-543X, 10 p.Article

Unsuspected pulmonary emboli in lung cancer patients: The impact on survival and the significance of anticoagulation therapySUN, Jong-Mu; TAE SUNG KIM; LEE, Jeeyun et al.Lung cancer. 2010, Vol 69, Num 3, pp 330-336, issn 0169-5002, 7 p.Article

Interaction between BCL2 and lnterleukin-10 Gene Polymorphisms Alter Outcomes of Diffuse Large B-Cell Lymphoma following Rituximab Plus CHOP ChemotherapyYEON HEE PARK; SANG KYUN SOHN; JONG GWANG KIM et al.Clinical cancer research (Print). 2009, Vol 15, Num 6, pp 2107-2115, issn 1078-0432, 9 p.Article

Small node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: Is there a subpopulation that might have benefit from adjuvant chemotherapy?YEON HEE PARK; IM, Seock-Ah; EUN YOON CHO et al.Breast cancer research and treatment. 2012, Vol 133, Num 1, pp 247-255, issn 0167-6806, 9 p.Article

The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancerMYUNG HEE CHANG; JIN SEOK AHN; LEE, Jeeyun et al.Lung cancer. 2010, Vol 69, Num 3, pp 323-329, issn 0169-5002, 7 p.Article

Comparison of Survival in Advanced Non-Small Cell Lung Cancer Patients in the Pre-and Post-Gefitinib ErasHYO SONG KIM; PARK, Keunchil; HYUN JUNG JUN et al.Oncology. 2009, Vol 76, Num 4, pp 239-246, issn 0030-2414, 8 p.Article

Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastasesSUN, Jong-Mu; JIN SEOK AHN; LEE, Soohyeon et al.Lung cancer. 2011, Vol 71, Num 1, pp 89-93, issn 0169-5002, 5 p.Article

The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patientsSUN, Jong-Mu; WON, Young-Woong; SEUNG TAE KIM et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 4, pp 687-694, issn 0171-5216, 8 p.Article

Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor statusYEON HEE PARK; LEE, Soohyeon; EUN YOON CHO et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 3, pp 507-516, issn 0344-5704, 10 p.Article